HTA projects — BMJ Group

Home > Our products > BMJ Evidence Centre > BMJ Technology Assessment Group > HTA projects

Email

Print

HTA projects

Research in progress

Single Technology Appraisal

Ranibizumab for the treatment of macular oedema caused by retinal vein occlusion (RVO)

Bevacizumab for the treatment of platinum-sensitive or partially platinum-sensitive recurrent advanced ovarian cancer

Mirabegron for the treatment of overactive bladder

Pixantrone dimaleate for monotherapy treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma

Ocriplasmin for treatment of vitreomacular traction including stage I and II macular holes with a diameter ≤400µm

Completed research

NIHR full report

Lithium or an atypical anti-psychotic in the management of treatment resistant depression: systematic review and economic evaluation

Single Technology Appraisal

Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation

Ivabradine for the treatment of chronic heart failure

Apixaban for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation

Other projects

Systematic review of the impact different metal femoral stems (MFSs) have on patient outcomes in total hip replacement (THR) due to osteoarthritis (OA)

HTA programme

HTA projects

About us

Publications

Useful links